Medication info
Phenova Tablet (Fenofibrate)

Phenova Tablet (Fenofibrate)

Prescription medicationTabletOral
Ingredient · strength
Fenofibrate›160mg / 1 tablet
Manufacturer / importer
Kyung Dong Pharmaceutical Co., Ltd.
Appearance
White, elongated film-coated tablet
Packaging
100 tablets (10 tablets/PTP x 10)
Approval status
Active

MFDS item code 201404451 · Approved 2014.09.29 · Insurance code 648103470

Summary

Main use
Treatment of primary hyperlipidemia (including hypercholesterolemia and hypertriglyceridemia)
Who takes it
Adults · Children
Adult dose
○ Adults: Administer 160 mg of fenofibrate orally once daily immediately after a meal. Fenofibrate must be administered in conjunction with dietary therapy. This drug may be less well absorbed on an empty stomach, so administer it immediately after a meal (except for the 145 mg formulation). ○ Elderly patients: Dose reduction is generally not necessary if renal function is not reduced. ○ Patients with renal impairment: Do not administer this drug to patients with moderate to severe renal impairment (serum creatinine 2.5 mg/dL or higher).
Child dose
○ Children: Clinical data on the use of this drug in children are not yet available.

Ingredients

Manufacturer
Kyung Dong Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of primary hyperlipidemia (including hypercholesterolemia and hypertriglyceridemia)

  • Primary hyperlipidemia
  • hypercholesterolemia
  • hypertriglyceridemia
View approved original text

This medication is used to treat primary hyperlipidemia, including hypercholesterolemia (Type IIa), mixed hyperlipidemia (Type IIb, III), and hypertriglyceridemia (Type IV).

How to take

Adult dose

○ Adults: Administer 160 mg of fenofibrate orally once daily immediately after a meal. Fenofibrate must be administered in conjunction with dietary therapy. This drug may be less well absorbed on an empty stomach, so administer it immediately after a meal (except for the 145 mg formulation). ○ Elderly patients: Dose reduction is generally not necessary if renal function is not reduced. ○ Patients with renal impairment: Do not administer this drug to patients with moderate to severe renal impairment (serum creatinine 2.5 mg/dL or higher).

Child dose

○ Children: Clinical data on the use of this drug in children are not yet available.

Precautions

This medication should not be used in patients with poor liver function. In patients with moderate to severe renal impairment, there is a risk of serious muscle damage called rhabdomyolysis, so it should not be administered. Women who are pregnant or may become pregnant, and breastfeeding women should not take this medication. Patients allergic to this medication or its ingredients should not use it. Patients with gallbladder disease or a history of gallstones should take caution when using this medication. Patients who have experienced photosensitivity or phototoxic reactions while taking fibrates or ketoprofen should not use this medication. This medication should not be used in children. Patients with biliary cirrhosis or pancreatitis should use this medication cautiously, and those with acute pancreatitis should consult a physician. Patients with lactose intolerance or specific genetic metabolic disorders should not take this medication. Patients with allergies to soybeans, peanuts, or soy oil should also avoid using this medication. Mildly impaired renal function patients may require dose adjustment or extended dosing intervals, and patients with liver function abnormalities should also use it with caution. Patients with hypoalbuminemia, a history of gallstones, those taking anticoagulants, and the elderly should be administered this medication carefully. This medication can affect the liver and biliary system, potentially causing elevated liver enzyme levels, hepatitis, or gallstones, so regular liver function tests are necessary. Skin rash, itching, and photosensitivity reactions may occur, and rarely, hair loss may happen. Neurological symptoms such as dizziness, headache, and weakness may appear. Due to the risk of thromboembolic events, attention should be given to vascular symptoms. If there are musculoskeletal reactions such as myalgia, muscle cramps, or elevations in creatine kinase, consult a physician immediately. Gastrointestinal symptoms may include abdominal pain, nausea, vomiting, and diarrhea, and in rare cases, pancreatitis may occur. This medication can affect blood coagulation, so blood tests and caution are needed. There are many interactions with other medications, especially with statins, anticoagulants, and antidiabetic agents, so caution is necessary when used together. It should not be taken during pregnancy as it can harm the fetus, and breastfeeding is also advised against. The elderly are at higher risk for adverse reactions due to decreased liver and renal function, so careful evaluation and regular testing are required before administration. There are no specific antidotes for overdose, and symptoms may be unclear, so the prescribed dosage must be strictly followed. Keep out of reach of children, and avoid transferring the medication to another container.

Side effects

  • Elevated serum aminotransferases
  • hepatomegaly
  • cholestatic hepatitis
  • gallstones
  • rash
  • itching
  • photosensitivity reactions
  • hair loss
  • weakness
  • hyperthermia
Show 39 more
  • dizziness
  • headache
  • peripheral neuropathy
  • thromboembolism
  • elevated creatine kinase
  • myalgia
  • muscle cramps
  • arthralgia
  • rhabdomyolysis
  • urticaria
  • photosensitive eczema
  • gastrointestinal disorders
  • abdominal pain
  • nausea
  • vomiting
  • diarrhea
  • abdominal distension
  • pancreatitis
  • hepatic porphyria
  • decreased hemoglobin
  • leukopenia
  • eosinophilia
  • elevated serum creatinine
  • eosinophilic pneumonia
  • ventricular arrhythmia
  • fatigue
  • sexual dysfunction
  • weight gain
  • mucous membrane syndrome
  • toxic epidermal necrolysis
  • skin rash
  • anaphylaxis
  • angioedema
  • DRESS syndrome
  • thrombocytopenia
  • agranulocytosis
  • myopathy
  • pulmonary embolism
  • deep vein thrombosis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly closed container to protect it from air or moisture. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

White, elongated film-coated tablet

Package unit

100 tablets (10 tablets/PTP x 10)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.